Concepts (136)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hippocampus | 14 | 2017 | 200 | 1.960 |
Why?
|
| Magnetic Resonance Imaging | 17 | 2023 | 875 | 1.120 |
Why?
|
| Epilepsy, Temporal Lobe | 5 | 2023 | 21 | 1.010 |
Why?
|
| Electroencephalography | 4 | 2024 | 70 | 0.970 |
Why?
|
| Alzheimer Disease | 11 | 2019 | 1414 | 0.870 |
Why?
|
| Entorhinal Cortex | 8 | 2012 | 21 | 0.860 |
Why?
|
| Memory Disorders | 3 | 2017 | 116 | 0.660 |
Why?
|
| Atrophy | 8 | 2014 | 68 | 0.620 |
Why?
|
| Memory | 6 | 2012 | 225 | 0.580 |
Why?
|
| Temporal Lobe | 4 | 2023 | 58 | 0.530 |
Why?
|
| Neural Pathways | 1 | 2017 | 54 | 0.520 |
Why?
|
| Nerve Fibers, Myelinated | 3 | 2012 | 25 | 0.510 |
Why?
|
| Epilepsy | 3 | 2018 | 58 | 0.380 |
Why?
|
| White Matter | 1 | 2014 | 113 | 0.380 |
Why?
|
| Parahippocampal Gyrus | 2 | 2011 | 4 | 0.350 |
Why?
|
| Amnesia | 2 | 2011 | 19 | 0.330 |
Why?
|
| Aging | 6 | 2018 | 1180 | 0.330 |
Why?
|
| Drug Resistant Epilepsy | 2 | 2023 | 10 | 0.320 |
Why?
|
| Brain Mapping | 5 | 2016 | 124 | 0.320 |
Why?
|
| Cerebral Cortex | 3 | 2017 | 132 | 0.310 |
Why?
|
| Female | 23 | 2018 | 13142 | 0.310 |
Why?
|
| Humans | 27 | 2024 | 23187 | 0.300 |
Why?
|
| Male | 20 | 2018 | 12659 | 0.290 |
Why?
|
| Organ Size | 7 | 2014 | 87 | 0.290 |
Why?
|
| Aged | 17 | 2018 | 7660 | 0.270 |
Why?
|
| Nerve Fibers | 1 | 2006 | 10 | 0.250 |
Why?
|
| Aged, 80 and over | 8 | 2012 | 3865 | 0.210 |
Why?
|
| Predictive Value of Tests | 6 | 2016 | 442 | 0.190 |
Why?
|
| Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels | 3 | 2018 | 9 | 0.190 |
Why?
|
| Perforant Pathway | 2 | 2012 | 4 | 0.180 |
Why?
|
| Cohort Studies | 4 | 2018 | 1467 | 0.180 |
Why?
|
| Cyclic Nucleotide-Gated Cation Channels | 2 | 2012 | 4 | 0.180 |
Why?
|
| Potassium Channels | 2 | 2012 | 36 | 0.180 |
Why?
|
| Longitudinal Studies | 3 | 2011 | 1106 | 0.170 |
Why?
|
| Neuroimaging | 3 | 2018 | 105 | 0.170 |
Why?
|
| Membrane Proteins | 2 | 2012 | 140 | 0.160 |
Why?
|
| Adult | 8 | 2017 | 6959 | 0.160 |
Why?
|
| Disease Progression | 5 | 2012 | 547 | 0.160 |
Why?
|
| Cognition Disorders | 3 | 2011 | 726 | 0.150 |
Why?
|
| Neurology | 1 | 2019 | 35 | 0.140 |
Why?
|
| Channelopathies | 1 | 2018 | 5 | 0.140 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2018 | 8 | 0.140 |
Why?
|
| Clinical Decision-Making | 1 | 2018 | 42 | 0.140 |
Why?
|
| Brain | 3 | 2011 | 1241 | 0.140 |
Why?
|
| Neuronal Plasticity | 1 | 2018 | 38 | 0.140 |
Why?
|
| Pyramidal Cells | 1 | 2018 | 34 | 0.140 |
Why?
|
| Young Adult | 5 | 2016 | 1657 | 0.130 |
Why?
|
| Functional Laterality | 5 | 2014 | 54 | 0.130 |
Why?
|
| Dementia | 2 | 2012 | 416 | 0.130 |
Why?
|
| Magnetoencephalography | 1 | 2017 | 2 | 0.130 |
Why?
|
| Brain Waves | 1 | 2016 | 4 | 0.130 |
Why?
|
| Electric Stimulation | 1 | 2016 | 46 | 0.130 |
Why?
|
| Cognition | 2 | 2014 | 1026 | 0.120 |
Why?
|
| Follow-Up Studies | 3 | 2018 | 1430 | 0.120 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2016 | 48 | 0.120 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2016 | 75 | 0.110 |
Why?
|
| Neurosurgical Procedures | 1 | 2016 | 115 | 0.110 |
Why?
|
| Biomarkers | 2 | 2014 | 486 | 0.100 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2014 | 139 | 0.100 |
Why?
|
| Risk | 1 | 2014 | 166 | 0.100 |
Why?
|
| Middle Aged | 9 | 2018 | 7981 | 0.090 |
Why?
|
| Axons | 1 | 2012 | 24 | 0.090 |
Why?
|
| Protein Subunits | 1 | 2011 | 17 | 0.090 |
Why?
|
| Gene Deletion | 1 | 2011 | 40 | 0.090 |
Why?
|
| Positron-Emission Tomography | 2 | 2010 | 75 | 0.090 |
Why?
|
| Headache | 1 | 2011 | 36 | 0.080 |
Why?
|
| Implantable Neurostimulators | 1 | 2010 | 5 | 0.080 |
Why?
|
| Seizures | 2 | 2023 | 62 | 0.080 |
Why?
|
| Frontal Lobe | 2 | 2011 | 57 | 0.080 |
Why?
|
| Neoplasms | 1 | 2010 | 218 | 0.070 |
Why?
|
| Depression | 1 | 2011 | 383 | 0.070 |
Why?
|
| Pain | 1 | 2010 | 332 | 0.070 |
Why?
|
| Analgesia, Epidural | 1 | 2007 | 54 | 0.070 |
Why?
|
| Verbal Learning | 2 | 2005 | 25 | 0.070 |
Why?
|
| Parkinson Disease | 1 | 2012 | 595 | 0.060 |
Why?
|
| Pain Measurement | 1 | 2007 | 412 | 0.060 |
Why?
|
| Adolescent | 3 | 2016 | 1884 | 0.060 |
Why?
|
| Retrospective Studies | 3 | 2018 | 2993 | 0.060 |
Why?
|
| Pain, Postoperative | 1 | 2007 | 272 | 0.050 |
Why?
|
| Treatment Outcome | 3 | 2018 | 2943 | 0.050 |
Why?
|
| Age Factors | 2 | 2018 | 651 | 0.050 |
Why?
|
| Proof of Concept Study | 1 | 2023 | 9 | 0.050 |
Why?
|
| Animals | 3 | 2018 | 3271 | 0.050 |
Why?
|
| Child | 2 | 2016 | 1160 | 0.050 |
Why?
|
| Reproducibility of Results | 3 | 2014 | 598 | 0.040 |
Why?
|
| Peroxins | 2 | 2012 | 2 | 0.040 |
Why?
|
| Protein Transport | 2 | 2012 | 29 | 0.040 |
Why?
|
| Algorithms | 1 | 2023 | 305 | 0.040 |
Why?
|
| Diffusion Tensor Imaging | 2 | 2012 | 49 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2012 | 363 | 0.040 |
Why?
|
| History, 21st Century | 1 | 2019 | 19 | 0.040 |
Why?
|
| History, 20th Century | 1 | 2019 | 28 | 0.040 |
Why?
|
| Reference Values | 3 | 2005 | 169 | 0.040 |
Why?
|
| Neuropsychological Tests | 2 | 2012 | 917 | 0.040 |
Why?
|
| Endoplasmic Reticulum | 1 | 2018 | 25 | 0.030 |
Why?
|
| Action Potentials | 1 | 2018 | 83 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2018 | 175 | 0.030 |
Why?
|
| Mice | 2 | 2012 | 1240 | 0.030 |
Why?
|
| Malformations of Cortical Development, Group I | 1 | 2017 | 2 | 0.030 |
Why?
|
| Sensory Thresholds | 1 | 2016 | 21 | 0.030 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2017 | 59 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 526 | 0.030 |
Why?
|
| Preoperative Care | 1 | 2016 | 107 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2016 | 569 | 0.030 |
Why?
|
| Internet | 1 | 2014 | 78 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2014 | 152 | 0.030 |
Why?
|
| Tissue Embedding | 1 | 2012 | 4 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2012 | 19 | 0.020 |
Why?
|
| Dentate Gyrus | 1 | 2012 | 5 | 0.020 |
Why?
|
| Subcellular Fractions | 1 | 2012 | 16 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2012 | 37 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2012 | 54 | 0.020 |
Why?
|
| Transfection | 1 | 2012 | 115 | 0.020 |
Why?
|
| Valproic Acid | 1 | 2011 | 13 | 0.020 |
Why?
|
| Logistic Models | 1 | 2012 | 357 | 0.020 |
Why?
|
| Mental Status Schedule | 1 | 2011 | 73 | 0.020 |
Why?
|
| Sclerosis | 1 | 2011 | 54 | 0.020 |
Why?
|
| Age of Onset | 1 | 2011 | 74 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 126 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2012 | 462 | 0.020 |
Why?
|
| Anticonvulsants | 1 | 2011 | 51 | 0.020 |
Why?
|
| Radioisotopes | 1 | 2010 | 13 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2011 | 216 | 0.020 |
Why?
|
| Genetic Therapy | 1 | 2011 | 83 | 0.020 |
Why?
|
| Rats | 1 | 2012 | 622 | 0.020 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2010 | 35 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2011 | 276 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2011 | 269 | 0.020 |
Why?
|
| Educational Status | 1 | 2011 | 223 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2010 | 210 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2010 | 377 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2011 | 778 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2011 | 804 | 0.020 |
Why?
|
| Incidence | 1 | 2007 | 633 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2003 | 85 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2004 | 314 | 0.010 |
Why?
|